Lotus Health Group Co. Hits Day High with 12.86% Surge

Lotus Health Group Co. has experienced a significant surge in its stock price, gaining 12.86% on March 19, 2026. The stock reached an intraday high of CNY 7.11, marking a notable performance against the backdrop of the broader market, as the China Shanghai Composite index declined by 1.39% on the same day. In terms of performance metrics, Lotus Health Group has shown resilience over the past week, with an 8.72% increase, while the one-month performance stands at 11.27%. Year-to-date, the stock has risen by 18.9%, contrasting sharply with the China Shanghai Composite's modest gain of 0.95%. Over the last three years, the stock has delivered an impressive return of 171.37%, significantly outperforming the market's 23.26% increase. Despite these positive trends, the company has faced challenges, including a return on equity of 14.42% and a price-to-book ratio of 5.81, indicating a relatively high valuation. Additionally, while profits have risen by 44.4% over the past year, the stock has underperformed the market, generating negative returns of -17.89%. Overall, Lotus Health Group Co. continues to navigate a complex financial landscape within the FMCG industry.